Impact of cost on prescribing diabetes medications for older adults with type 2 diabetes in the outpatient setting.
Res Social Adm Pharm
; 20(8): 755-759, 2024 08.
Article
en En
| MEDLINE
| ID: mdl-38697890
ABSTRACT
BACKGROUND:
Newer diabetes medications have cardiorenal benefits beyond blood sugar lowering that make them a preferred treatment option in many patients. Despite this, studies have shown that prescribing of these medications remains suboptimal with medication costs being hypothesized as a reason for underutilization.OBJECTIVE:
To understand clinicians' decision-making processes for prescribing diabetes medications in older adults, focusing on higher cost medications.METHODS:
Observations of patient encounters and semi-structured interviews were conducted with clinicians from primary care, endocrinology, and geriatrics to elucidate themes into diabetes medication prescribing. A qualitative descriptive approach was used to analyze the data from interviews using an inductive coding scheme with themes derived from the data.RESULTS:
Twenty-one interviews were conducted. Five themes were identified 1) out-of-pocket costs drive prescribing decisions 2) out-of-pocket costs can be variable due to changing insurance plans or changing coverage 3) clinicians have difficulty with determining patient-specific out-of-pocket costs 4) clinicians manage the tradeoffs existing between cost, efficacy, and safety and 5) clinicians can use cost-modifying strategies such as patient assistance.CONCLUSION:
Addressing the challenges that medication costs pose to prescribing evidence-based medications for type 2 diabetes is necessary to optimize diabetes care for older adults.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Diabetes Mellitus Tipo 2
/
Hipoglucemiantes
Límite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Res Social Adm Pharm
Asunto de la revista:
FARMACIA
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Estados Unidos